Based on the functional crosstalk of EGFR and VEGFR-2 through shared common downstream signalling pathways31, it is inferred that the simultaneous inhibition of both EGFR and VEGFR is an effective approach for overcoming the reported resistance in NSCLC.32 This evidence concerns the gene EGFR and non-small cell lung carcinoma.